Apple
AAPL
D.R. Horton
DHI
Alphabet-A
GOOGL
Alphabet-C
GOOG
KB Home
KBH
US Stock MarketDetailed Quotes
CARM Carisma Therapeutics
- 0.403
- +0.002+0.52%
Trading Mar 4 10:48 ET
16.80MMarket Cap-0.26P/E (TTM)
0.419High0.390Low88.48KVolume0.400Open0.400Pre Close35.86KTurnover0.29%Turnover RatioLossP/E (Static)41.75MShares2.66052wk High-1.51P/B12.16MFloat Cap0.38052wk Low--Dividend TTM30.22MShs Float51.357Historical High--Div YieldTTM7.32%Amplitude0.380Historical Low0.405Avg Price1Lot Size
Carisma Therapeutics News
Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Carisma Therapeutics Appoints Interim VP of Finance
Express News | Carisma Therapeutics Inc: On Dec 24, Appoints Natalie Mcandrew as Principal Financial Officer
H.C. Wainwright Downgrades Carisma Therapeutics(CARM.US) to Hold Rating
Express News | HC Wainwright & Co. Downgrades CARISMA Therapeutics to Neutral
Carisma Downgraded by Baird Over Lack of Near-term Catalysts
Express News | D. Boral Capital Maintains Buy on CARISMA Therapeutics, Maintains $12 Price Target
Carisma Therapeutics Price Target Cut to $1.00/Share From $10.00 by Baird
Baird Downgrades Carisma Therapeutics(CARM.US) to Hold Rating, Cuts Target Price to $1
BTIG Maintains Carisma Therapeutics(CARM.US) With Hold Rating
Carisma Therapeutics: Hold Rating Amid Strategic Shift and Uncertain Pipeline Prospects
Express News | Carisma Therapeutics Inc : Baird Cuts to Neutral Rating; Cuts Target Price to $1 From $10
Carisma Therapeutics Cut to In-Line From Outperform by Evercore ISI Group
Carisma Therapeutics Price Target Cut to $0.70/Share From $4.00 by Evercore ISI Group
Evercore Downgrades Carisma Therapeutics(CARM.US) to Hold Rating, Cuts Target Price to $0.7
Carisma Therapeutics Cut to Neutral From Buy by BTIG
BTIG Downgrades Carisma Therapeutics(CARM.US) to Hold Rating
BTIG Downgrades Carisma Therapeutics (CARM) to a Hold
Express News | Carisma Therapeutics Inc - Chief Financial Officer, Richard Morris Will Leave Company Effective Dec 31
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.